2 Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide

3 Dengue associated hemophagocytic lymphohistiocytosis: a case series

4 Dengue infection associated hemophagocytic syndrome: Therapeutic interventions and outcome

5 Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India

6 The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis

7 Critical care management of patients with hemophagocytic lymphohistiocytosis

8 Haemophagocytic lymphohistiocytosis: a case series from Mumbai

9 Hemophagocytosis in dengue: comprehensive report of six cases

10 Familial and acquired hemophagocytic lymphohistiocytosis

11 Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

12 Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

13 Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society

14 HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

15 Infection associated haemophagocytic syndrome in severe dengue infection - a case series in a district hospital

16 Hemophagocytic lymphohistiocytosis syndrome in Dengue hemorrhagic fever

17 Incidence and Risk Factors for Developing Dengue-Associated Hemophagocytic Lymphohistiocytosis in Puerto Rico, 2008 - 2013

18 Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group

19 Dengue hemophagocytic syndrome: A systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors

20 Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis

21 Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome

22 hemophagocytic lymphohistiocytosis complicating myelodysplasia

23 Unusual Presentation of Hemophagocytic Lymphohistiocytosis in a Kidney Transplant Patient

24 Histoplasmosis, heart failure, hemolysis and haemophagocytic lymphohistiocytosis.

25 Epstein-Barr Virus Primary Infection Complicated by Hemophagocytic Lymphohistiocytosis and Plasmablastic Lymphoma in a HIV-Negative Patient.

26 Takotsubo cardiomyopathy secondary to haemophagocytic lymphohistiocytosis in HIV patients: a comprehensive review.

27 Tuberculosis-associated hemophagocytic lymphohistiocytosis with subsequent unmasking cryptococcal immune reconstitution inflammatory syndrome (IRIS) in an HIV-negative man.

28 Hemophagocytic lymphohistiocytosis associated with oxcarbazepine.

29 Intravascular Large B-cell Lymphoma Associated with Systemic and Central Nervous System Hemophagocytic Lymphohistiocytosis: A Case Report.

30 Hemophagocytic lymphohistiocytosis: a case series of a Brazilian institution

31 Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

32 Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue

33 Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society

34 Human Herpesvirus 8-Associated Hemophagocytic Lymphohistiocytosis in Human Immunodeficiency Virus-Infected Patients

35 Familial and acquired hemophagocytic lymphohistiocytosis

36 Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis

37 Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

38 Critical care management of patients with hemophagocytic lymphohistiocytosis

39 Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India

40 Incidence and Risk Factors for Developing Dengue-Associated Hemophagocytic Lymphohistiocytosis in Puerto Rico, 2008 - 2013

41 Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center

42 Hemophagocytic Lymphohistiocytosis Syndrome in Dengue Hemorrhagic Fever

43 Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome

44 clinical characteristics and disease course in children with haemophagocytic lymphohistiocytosis treated at the university children’s hospital in belgrade

45 successful resolution of epsteinâbarr virus-associated hemophagocytic lymphohistiocytosis during the treatment course of acute lymphoblastic leukemia

46 combination immunosuppressive therapy including rituximab for epstein-barr virus-associated hemophagocytic lymphohistiocytosis in adult-onset still’s disease

47 mitochondrial disease as a cause of neonatal hemophagocytic lymphohistiocytosis

48 the frequency of a91v in the perforin gene and the effect of tumor necrosis factor-α promoter polymorphism on acquired hemophagocytic lymphohistiocytosis

49 report of a fatal pediatric case of hemophagocytic lymphohistiocytosis associated with pandemic influenza a (h1n1) infection in 2009

50 hemophagocytic lymphohistiocytosis complicating dengue and plasmodium vivax coinfection

51 graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice

52 a hemophagocytic lymphohistiocytosis case with newly defined unc13d (c.175g>c; p.ala59pro) mutation and a rare complication

Keyword Connections

Journals

Research Groups

Bibliographies